Loading...
NPI 1750047049 · Richardson, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Curie Dx Laboratory LLC is a clinical medical laboratory provider located in Richardson, Texas. This profile covers 25 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Curie Dx Laboratory LLC |
| Address | 833 E Arapaho Rd Ste 102 |
| City | Richardson |
| State | TX |
| ZIP | 75081 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 11, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $664.4K |
| Medicaid | $2.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 6,260 | $30 | $212.9K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 9,540 | $10 | $114.5K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 1,530 | $30 | $51.9K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 310 | $140 | $43.7K |
| 87502 | The lab analyst performs a test to determine the presence of multiple types or subtypes of influenza virus through nucleic acid detection using multiplex amplified probe technique and possibly… | 260 | $90 | $24.4K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 560 | $30 | $19.1K |
| 87634 | The lab analyst performs a test for respiratory syncytial virus (RSV) antigen detection using amplified nucleic acid probe technique. | 260 | $70 | $17.9K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 510 | $30 | $17.5K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 510 | $30 | $17.5K |
| 86413 | The lab analyst performs an immunoassay to quantify the level of antibodies to the SARS–CoV–2 virus in the patient specimen, such as blood. | 260 | $40 | $10.7K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 49 | 300 | 790 | $30 | $265.1K |
| K1034 | 60 | 2,490 | 450 | $10 | $117.8K |
| 87631 | 15 | 90 | 50 | $140 | $90.1K |
| 86413 | 3 | 10 | 260 | $40 | $76K |
| 87481 | 52 | 270 | 150 | $30 | $68.8K |
| U0003 | 30 | 60 | 100 | $70 | $64.7K |
| 87634 | 5 | 50 | 30 | $70 | $56.8K |
| 87498 | 12 | 30 | 120 | $30 | $45.9K |
| 87503 | 3 | 10 | 210 | $30 | $44.3K |
| 87541 | 14 | 40 | 140 | $30 | $40.8K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 290 | $10 | $2.9K |
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 186 | 340 | 400 | $50 | $553.5K |
Other providers in the same ZIP code as Curie Dx Laboratory LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Caregivers Home Health Tx Inc | TX | Home Health Agency | $0 | $478M |
| Apple Homecare Medical Supply LLC | TX | Durable Medical Equipment & Medical Supplies | $0 | $123.3M |
| Hope Pediatrics LLC | TX | Home Health Agency | $0 | $77.9M |
| Abc Home Medical Supply, Inc. | TX | Durable Medical Equipment & Medical Supplies | $0 | $22.8M |
| Trident Diagnostics Limited Liability Company | TX | Clinical Medical Laboratory | $14.9M | $66.7K |
| Rfa Medical Solutions LLC | TX | Clinical Medical Laboratory | $6.4M | $0 |
| Cabot Lab LLC | TX | Clinical Medical Laboratory | $278.1K | $1.2M |
| Shahida Rafiq | TX | Family Medicine Physician | $232.7K | $0 |
| Pearl Ezegrim | TX | Psychiatric/Mental Health Nurse Practitioner | $110.1K | $40 |
| Francis Lister | TX | Optometrist | $23.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.